Characteristics of persons with multiple sclerosis covered by public drug insurance in a Quebec Birth Cohort

IF 2.4 3区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Yasmine Sadou , Miceline Mésidor , Marie-Claude Rousseau
{"title":"Characteristics of persons with multiple sclerosis covered by public drug insurance in a Quebec Birth Cohort","authors":"Yasmine Sadou ,&nbsp;Miceline Mésidor ,&nbsp;Marie-Claude Rousseau","doi":"10.1016/j.pmedr.2025.103093","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>People living with multiple sclerosis use medications for several indications, but little is known about their prescription drug use in Quebec, notably because the public drug insurance covers only part of the population. We compared the characteristics of those with public drug insurance to those privately covered.</div></div><div><h3>Methods</h3><div>In a cohort of persons born in 1970–1974, we identified those living with multiple sclerosis by applying a validated algorithm to administrative health data. Individuals with public coverage were those who had at least one covered period after their date of diagnosis between January 1, 1997, and December 31, 2014. We used descriptive statistics to compare sociodemographic and healthcare utilization characteristics by type of coverage.</div></div><div><h3>Results</h3><div>Among the 1363 persons living with multiple sclerosis, 720 (53 %) were covered by the public drug insurance. Individuals with public drug coverage were younger, more likely to be materially and socially deprived, and had a lower median income than those with private insurance, but otherwise had similar sociodemographic characteristics. The proportion of people who had at least one multiple sclerosis-related visit to a general practitioner (39 % versus 45 %) and hospitalization (6 % versus 3 %) differed among those with public compared to private coverage. However, the utilization of other health services, including neurologist consultations, did not differ by type of drug coverage.</div></div><div><h3>Conclusion</h3><div>People with multiple sclerosis covered by the public and private drug insurance differed in terms of age, income, deprivation, multiple sclerosis-related visits to a general practitioner and hospitalizations, but not neurologist consultations.</div></div>","PeriodicalId":38066,"journal":{"name":"Preventive Medicine Reports","volume":"54 ","pages":"Article 103093"},"PeriodicalIF":2.4000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Preventive Medicine Reports","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211335525001329","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

People living with multiple sclerosis use medications for several indications, but little is known about their prescription drug use in Quebec, notably because the public drug insurance covers only part of the population. We compared the characteristics of those with public drug insurance to those privately covered.

Methods

In a cohort of persons born in 1970–1974, we identified those living with multiple sclerosis by applying a validated algorithm to administrative health data. Individuals with public coverage were those who had at least one covered period after their date of diagnosis between January 1, 1997, and December 31, 2014. We used descriptive statistics to compare sociodemographic and healthcare utilization characteristics by type of coverage.

Results

Among the 1363 persons living with multiple sclerosis, 720 (53 %) were covered by the public drug insurance. Individuals with public drug coverage were younger, more likely to be materially and socially deprived, and had a lower median income than those with private insurance, but otherwise had similar sociodemographic characteristics. The proportion of people who had at least one multiple sclerosis-related visit to a general practitioner (39 % versus 45 %) and hospitalization (6 % versus 3 %) differed among those with public compared to private coverage. However, the utilization of other health services, including neurologist consultations, did not differ by type of drug coverage.

Conclusion

People with multiple sclerosis covered by the public and private drug insurance differed in terms of age, income, deprivation, multiple sclerosis-related visits to a general practitioner and hospitalizations, but not neurologist consultations.
魁北克出生队列中公共药品保险覆盖的多发性硬化症患者的特征
目的多发性硬化症患者使用药物治疗多种适应症,但在魁北克,人们对他们的处方药使用情况知之甚少,主要是因为公共药物保险只覆盖了部分人口。我们比较了公共药品保险和私人药品保险的特点。方法在1970-1974年出生的人群中,我们通过对行政健康数据应用经过验证的算法来识别患有多发性硬化症的人群。拥有公共保险的个人是那些在1997年1月1日至2014年12月31日期间诊断后至少有一个覆盖期的人。我们使用描述性统计来比较按覆盖类型划分的社会人口统计学和医疗保健利用特征。结果1363例多发性硬化症患者中,参保人数为720人(53%)。拥有公共药物保险的个人更年轻,更有可能在物质和社会上被剥夺,收入中位数低于拥有私人保险的人,但在其他方面具有相似的社会人口学特征。与私营保险相比,至少有一次与多发性硬化症相关的全科医生就诊的人(39%对45%)和住院治疗的人(6%对3%)的比例在公共保险和私营保险中有所不同。然而,利用其他保健服务,包括神经科医生会诊,并没有因药物覆盖类型而有所不同。结论公共和私人药品保险覆盖的多发性硬化症患者在年龄、收入、剥夺、与多发性硬化症相关的全科医生就诊次数和住院次数等方面存在差异,但在神经科医生就诊方面没有差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Preventive Medicine Reports
Preventive Medicine Reports Medicine-Public Health, Environmental and Occupational Health
CiteScore
3.90
自引率
0.00%
发文量
353
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信